@ARTICLE{
author={Trukhin Dmytro|,Poddubskaya Elena|,Andric Zoran G|0000-0002-1495-2729,Bondarenko Igor N|,Shevnia Serhii|,Zaric Bojan|0000-0003-3215-8390,Bellala Ravishankar|,Charoentum Chaiyut|,Perez Luis|,Bullo Felicitas|,Garcia Fernanda|},
year={2021},
title={Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={39},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Millan Susana|,Trukhin Dmytro|,Kolesnik Oleksii|,Poddubskaya Elena|,Andric Zoran G|0000-0002-1495-2729,Bondarenko Igor N|,Shevnia Serhii|,Bullo Felicitas|,Sarnago Cristina|},
year={2020},
title={Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={38},
number={15},
pages={-},
document_type={Meeting Abstract},
}